FBT 股价预测及 ETF 分析 - 分红·管理费·持仓·NAV·RSI·MACD | 美股今日
详细指标表
| Category | US Equities - Industry Sector | Expense | 0.55% | Return% 1Y | 43.8% | Total Holdings | 31 | Perf Week | 2.14% | Volume | 60,260 |
| Asset Type | Equities (Stocks) | AUM | $3.01B | Return% 3Y | 23.58% | NAV | $272.54 | Perf Month | -1.48% | Avg Volume | 0.08M |
| ETF Type | US Equities | Dividend TTM | - | Return% 5Y | 10.74% | 52W High | -2.17% | Perf Quarter | 9.12% | Rel Volume | 0.76 |
| Active/Passive | Passive | Div Gr. 3/5Y | - | Return% 10Y | 11.65% | 52W Low | 44.6% | Perf Half Y | 31.96% | Prev Close | $272.68 |
| IPO | 2006/6/23 | Flows% 1M | 1.33% | Return% SI | 13.83% | RSI (14) | 52.51 | Perf YTD | 30.37% | Price | $269.25 |
| Beta | 0.68 | Flows% 3M | -2.31% | Flows% YTD | 49.89% | Flows% 1Y | 56.24% | Perf Year | 42.19% | Volatility(W/M) | 1.36% 1.77% |
| SMA20 | 0.74% | SMA50 | 0.57% | SMA200 | 16.35% | ATR | 4.89 | ||||
First Trust NYSE Arca Biotechnology Index Fund seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the NYSE Arca Biotechnology Index. The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of a cross section of small, mid and large capitalization companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services.
前10大持仓占 基金的43%
按持仓比重从大到小。
过去1年中, 属于较高水平
较一年最高价低 2%。
成交量低于平时。 相当于平均成交量的76%。
若长期持有, 跑赢大盘
如果5年前买入,现在的收益率是+64.1%。 同期标普500为+68%。
点击查看数字
价格 波动较大
最糟糕时(2021年2月)下跌了32%,用了961天才恢复。
点击查看数字
没有股息
目前还没有可分配的利润。
资金持续流入
最近一年流入了相当于资产56.2%的新资金。
点击查看数字